Francesco Marincola, M.D.
Francesco Marincola, M.D. is the Chief Scientific Officer of Refuge Biotech and past President of SITC. Previously, he held positions as head of the genetic research institute at Sidra Medical and Research Center as well as Chief of the Infectious Disease and Immunogenetics Section in the Department of Transfusion Medicine at the Clinical Center of the NIH in Bethesda. He was founder and serves as Editor-in-Chief, for the Journal of Translational Medicine and ASHI Quarterly, senior editor for the Journal of the American Society for Histocompatibility and Immunogenetics, and editor for a variety of academic journals.
His research is focused on tumor immunology by developing strategies for studying tumor-host interactions in the context of human genetic polymorphism and cancer heterogeneity. The NIH Immunogenetics Laboratory is recognized nationally and internationally for the cutting edge technologies applied to the study of genetic materials at the genomic, transcriptional, epigenetic and mutational level. In particular, Dr Marincola’s laboratory has developed techniques to continuously study tumors in vivo during the dynamic response to immunotherapy.
Dr. Marincola received his M.D. degree from the University of Milan, and his surgery training at Stanford University. He has published more than 600 original articles, reviews, editorials, and books.